# A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

> **NCT05027061** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 11776 (actual)

## Conditions studied

- Non-Valvular Atrial Fibrillation (NVAF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05027061
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-02
- **Primary completion:** 2021-12-04
- **Final completion:** 2021-12-04
- **Target enrollment:** 11776 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027061, "A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05027061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*